USD 0.0
(0.0%)
Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | - | 62.8 Thousand | 58.34 Thousand | 465.00 | 18.52 Thousand | 37.14 Thousand |
Selling, General and Administrative Expenses | - | 62.8 Thousand | 58.34 Thousand | 465.00 | 18.52 Thousand | 37.14 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | - | 62.8 Thousand | 58.34 Thousand | 465.00 | 18.52 Thousand | 37.14 Thousand |
Operating Income | - | -62.8 Thousand | -58.34 Thousand | -465.00 | -18.52 Thousand | -37.14 Thousand |
Interest Expense | - | 13.56 Thousand | 4592.00 | 2920.00 | 2799.00 | 4378.00 |
Income Tax Expense | - | 13.56 Thousand | 4592.00 | 2920.00 | -161.14 Thousand | -37.14 Thousand |
Earnings before Tax | - | -76.37 Thousand | -62.93 Thousand | -3385.00 | -21.32 Thousand | -41.52 Thousand |
Net Income | - | -89.93 Thousand | -67.53 Thousand | -6305.00 | -21.32 Thousand | -41.52 Thousand |
Earnings Per Share Basic | - | -0.02 | -0.01 | -0.00 | -0.00 | -0.01 |
Earnings Per Share Diluted | - | -0.02 | -0.01 | -0.00 | -0.00 | -0.01 |
Weighted Average Shares Outstanding | - | 5.74 Million | 5.66 Million | 5.66 Million | 5.66 Million | 5.29 Million |
Weighted Average Shares Outstanding (Diluted) | - | 5.74 Million | 5.66 Million | 5.66 Million | 5.66 Million | 5.29 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | - | -62.8 Thousand | -58.34 Thousand | -465.00 | -18.52 Thousand | -37.14 Thousand |
Earnings Before Tax Margin | - | - | - | - | - | - |
Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | - | - | - | - | - | 14.49 Thousand |
Selling, General and Administrative Expenses | - | - | - | - | - | 14.49 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | - | - | - | - | - | 14.49 Thousand |
Operating Income | - | - | - | - | - | -14.49 Thousand |
Interest Expense | - | - | - | - | - | 4946.00 |
Income Tax Expense | - | - | - | - | - | -14.49 |
Earnings before Tax | - | - | - | - | - | -19.43 Thousand |
Net Income | - | - | - | - | - | -19.43 Thousand |
Earnings Per Share Basic | - | - | - | - | - | -0.00 |
Earnings Per Share Diluted | - | - | - | - | - | -0.00 |
Weighted Average Shares Outstanding | - | - | - | - | - | 7 Million |
Weighted Average Shares Outstanding (Diluted) | - | - | - | - | - | 7 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | -14.49 Thousand |
Earnings Before Tax Margin | - | - | - | - | - | - |
QUICKHEAL
MATI
IFNNF
AQST
RFLL
GENE